Patent 10471072 was granted and assigned to TherapeuticsMD on November, 2019 by the United States Patent and Trademark Office.
In one aspect, pharmaceutical compositions and methods for the treatment of vulvovaginal atrophy (VVA) are provided. In one embodiment, the method comprises digitally inserting into the lower third of the vagina of a subject having VVA a soft gelatin capsule containing a liquid pharmaceutical composition.